Browsing Tag
Celltrion Inc.
2 posts
How Celltrion’s $330m Eli Lilly deal positions it for a new era of U.S. biomanufacturing
Celltrion’s $330M purchase of Eli Lilly’s U.S. plant signals a tariff-proof pivot in biosimilars, reshaping pharma manufacturing in the U.S. today.
Abpro and Celltrion reveal promising preclinical results for ABP-102/CT-P72 at AACR 2025
Discover how Abpro and Celltrion’s ABP-102/CT-P72 could reshape HER2 cancer treatment with promising preclinical results. Read the full details now!